- Clinical Chemistry
- Rapid Diagnostic Test
- Research Use Only
- Life Science
- USER AREA
BPRO (BPPT-PROLINE) is a form of collaboration and joint commitment between researchers and the medical device industry in the application of technology, provision of quality, and innovative medical devices.
BPRO COVID-19 Ag Rapid Diagnostic Test is a rapid immunochromatographic assay for the qualitative detection of specific antigen against the SARS-CoV-2 nucleocapsid protein in nasopharyngeal swab samples.
The clinical performance of the BPRO COVID-19 Ag Rapid Diagnostic Test has been validated by a laboratory appointed by the Indonesian Ministry of Health, using 60 nasopharyngeal swab specimens that tested for nucleic acid examination (PCR), as 30 positive samples with CT≤25 values and 30 negative samples.
For information on specifications, services and other documents related to products, please contact our Customer Service team.